Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$14.10
+12.40%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$19.00
Range $18.00 – $20.00
Implied Upside
+34.8%
Consensus $19.00 vs current $14.10
NASDAQ·Healthcare·Biotechnology
$14.10
+12.40%
Mkt Cap $13.31M
No recent rating data.
Price Target (2 analysts)
$19.00
Range $18.00 – $20.00
+34.8%
Consensus $19.00 vs current $14.10